Hanneke C. Kluin‐Nelemans

University Medical Center Groningen — Netherlands

Medicine · Health Sciences

84h-index26.5kcitations587works3.52yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Lymphoma Diagnosis and Treatment(213), Chronic Lymphocytic Leukemia Research(128), Mast cells and histamine(82), Viral-associated cancers and disorders(68), Immune Cell Function and Interaction(39)

Publications585 total

Marked survival gains in patients ≤ 65 years with advanced-stage mantle cell lymphoma: a pooled analysis of six randomized phase III trials, 1996-2020
Haematologica·2025Open Access
133 | LONG‐TERM SURVIVAL TRENDS IN ADVANCED‐STAGE MANTLE CELL LYMPHOMA: A POOLED ANALYSIS OF SIX RANDOMIZED PHASE III TRIALS FROM 1996 TO 2020
Hematological Oncology·2025· 1 citedOpen Access
58 | DETECTION AND CLINICAL IMPACT OF SUBCLONAL TP53 MUTATIONS AND CHIP IN PATIENTS WITH MCL: RESULTS FROM THE EU‐MCL NETWORK TRIALS
Hematological Oncology·2025Open Access
Validation of POD24 as a robust early clinical indicator of poor survival in mantle cell lymphoma from 1280 patients on clinical trials, a LYSA study
Blood Cancer Journal·2025· 3 citedOpen Access
BR or R-CHOP induction with rituximab maintenance in untreated, transplant-ineligible patients with mantle cell lymphoma
Blood Advances·2025· 2 citedOpen Access
Concordance between late effects reported by physicians and patients in a cohort of long-term Hodgkin lymphoma survivors: an analysis of data from nine consecutive EORTC-LYSA trials
Journal of Cancer Survivorship·2024Open Access
Comprehensive genetic analysis by targeted sequencing identifies risk factors and predicts patient outcome in Mantle Cell Lymphoma: results from the EU-MCL network trials
Leukemia·2024· 14 citedOpen Access
Relationships, marriage, and partner abandonment among Hodgkin lymphoma survivors treated in nine EORTC-GELA Lymphoma Group trials
Leukemia & lymphoma/Leukemia and lymphoma·2024Open Access
Comprehensive genetic analysis by targeted sequencing identifies risk factors and predicts patient outcome in Mantle Cell Lymphoma: results from the EU-MCL network trials
2024Open Access
Prevalence of hypersensitivity reactions in various forms of mastocytosis: A pilot study of 2485 adult patients with mastocytosis collected in the ECNM registry
Allergy·2024· 16 citedOpen Access
Serum chemistry profiling and prognostication in systemic mastocytosis: a registry-based study of the ECNM and GREM
Blood Advances·2024· 6 citedOpen Access
BR or R-CHOP induction followed by rituximab maintenance in transplant-ineligible patients with mantle cell lymphoma
2024Open Access
Predictive Value of Minimal Residual Disease for Efficacy of Rituximab Maintenance in Mantle Cell Lymphoma: Results From the European Mantle Cell Lymphoma Elderly Trial
Journal of Clinical Oncology·2023· 14 citedOpen Access
Characteristics, primary treatment, and survival of MDS/MPN with neutrophilia: a population-based study
Blood Advances·2023· 7 citedOpen Access
Validation of POD24 As a Robust Early Clinical End Point of Poor Survival in Mantle Cell Lymphoma from 1280 Patients on Clinical Trials
Blood·2023· 9 cited
Induction and Maintenance Therapy in Elderly Patients with Mantle Cell Lymphoma: Double-Randomized MCL R2 Elderly Clinical Trial By the European Mantle Cell Lymphoma Network
Blood·2023· 9 cited
Clinical outcome of Mantle Cell Lymphoma patients with high-risk disease (high-risk MIPI-c or high p53 expression)
Leukemia·2023· 48 citedOpen Access
Work and education interruption in long-term Hodgkin lymphoma survivors: an analysis among patients from nine EORTC-LYSA trials
Acta Oncologica·2023· 5 citedOpen Access
Supplemental Table S3 from Advances in the Classification and Treatment of Mastocytosis: Current Status and Outlook toward the Future
2023Open Access
Supplemental Table S2 from Advances in the Classification and Treatment of Mastocytosis: Current Status and Outlook toward the Future
2023Open Access
page 1 of 30Next →

Frequent Co-authors

Olivier Hermine(17), Peter Valent(9), Cem Akin(9), Karin Hartmann(9), Karl Sotlar(9), Martin Dreyling(8), Wolfgang R. Sperr(8), Michel Arock(8), Massimo Triggiani(8), Alberto Órfão(8), Dean D. Metcalfe(8), Jason Gotlib(8), Knut Brockow(7), Lawrence B. Schwartz(7), Jan Walewski(7), Andreas Reiter(7), E.M. Noordijk(7), Eva Hoster(6), Luís Escribano(6), José Thomas(6)